Aristotle Atlantic Partners, LLC Biomarin Pharmaceutical Inc Transaction History

Aristotle Atlantic Partners, LLC

  • $3.19 Billion
  • Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 4,032 shares of BMRN stock, worth $258,814. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,032
Previous 33,310 87.9%
Holding current value
$258,814
Previous $2.74 Million 89.68%
% of portfolio
0.01%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $2.02 Million - $2.75 Million
-29,278 Reduced 87.9%
4,032 $283,000
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $56,566 - $70,087
-760 Reduced 2.23%
33,310 $2.74 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $105,600 - $124,740
-1,260 Reduced 3.57%
34,070 $2.98 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $39,710 - $51,323
521 Added 1.5%
35,330 $3.41 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $1.01 Million - $1.12 Million
11,837 Added 51.53%
34,809 $3.08 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $1.52 Million - $1.75 Million
17,491 Added 319.12%
22,972 $1.99 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $480,902 - $642,756
5,481 New
5,481 $532,000
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $1.87 Million - $2.14 Million
-25,000 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$80.14 - $106.07 $16,028 - $21,214
-200 Reduced 0.79%
25,000 $2.13 Million
Q2 2018

Aug 14, 2018
SELL
$76.01 - $99.03 $547,272 - $713,016
-7,200 Reduced 22.22%
25,200 $2.37 Million
Q1 2018

Sep 10, 2018
BUY
$77.67 - $92.63 $2.52 Million - $3 Million
32,400 New
32,400 $2.63 Million
Q1 2018

May 14, 2018
SELL
$77.67 - $92.63 $2.52 Million - $3 Million
-32,400 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $2.62 Million - $3.08 Million
32,400
32,400 $2.89 Million

Others Institutions Holding BMRN

# of Institutions
643
Shares Held
178M
Call Options Held
2M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.9B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Aristotle Atlantic Partners, LLC Portfolio

Follow Aristotle Atlantic Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email